Recommendations for screening and detection of connective tissue disease-associated pulmonary arterial hypertension - Wikidata - wikimedia - TriplyDB

Recommendations for screening and detection of connective tissue disease-associated pulmonary arterial hypertension

Recommendations for screening and detection of connective tissue disease-associated pulmonary arterial hypertension

http://www.wikidata.org/entity/Q30562538

about

Systemic Sclerosis and Malignancy: A Review of Current Data Systemic sclerosis: commonly asked questions by rheumatologists Borderline pulmonary arterial pressure in systemic sclerosis patients: a post-hoc analysis of the DETECT study Stress Doppler echocardiography for early detection of systemic sclerosis-associated pulmonary arterial hypertension.Old medications and new targeted therapies in systemic sclerosis.Comparison of Treatment Response in Idiopathic and Connective Tissue Disease-associated Pulmonary Arterial Hypertension Noninvasive model including right ventricular speckle tracking for the evaluation of pulmonary hypertension.Is early diagnosis of pulmonary arterial hypertension possible in inflammatory rheumatic diseases? Experience from a single center in Turkey.Screening and diagnostic modalities for connective tissue disease-associated pulmonary arterial hypertension: a systematic review.Personalized medicine in systemic sclerosis: facts and promises.Pulmonary veno-occlusive disease: a rare cause of pulmonary hypertension in systemic sclerosis. Case presentation and review of the literature .Current Approaches to the Treatment of Systemic-Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH).Pulmonary hypertension: diagnostic approach and optimal management.Echocardiography in the Assessment of Patients with Rheumatologic Diseases.Pulmonary hypertension in connective tissue diseases: an update.Six-Minute Walk Test as a Predictor of Diagnosis, Disease Severity, and Clinical Outcomes in Scleroderma-Associated Pulmonary Hypertension: The DIBOSA Study.Autologous hematopoietic stem cell therapy in severe systemic sclerosis: ready for clinical practice?Pulmonary arterial hypertension associated with connective tissue diseases: A review focusing on distinctive clinical aspects.Screening and Early Detection of Pulmonary Arterial Hypertension in Connective Tissue Diseases. It Is Time to Institute It!No changes in N-terminal pro-brain natriuretic peptide in a longitudinal cohort of patients with systemic sclerosis-associated pulmonary arterial hypertension on therapy with bosentan.Interstitial lung disease points to consider for clinical trials in systemic sclerosis.Evaluation and management approaches for scleroderma lung disease.Rationale and design of the screening of pulmonary hypertension in systemic lupus erythematosus (SOPHIE) study.Lung Involvements in Rheumatic Diseases: Update on the Epidemiology, Pathogenesis, Clinical Features, and Treatment.Incremental Shuttle Walking Test Distance Is Reduced in Patients With Pulmonary Hypertension in World Health Organisation Functional Class I.Systemic sclerosis: state of the art on clinical practice guidelines

P2860

Q26740318-E19AFCEE-4551-4551-9E11-1BFA82E9A2F4 Q27021067-A2D5C465-8462-474E-8397-22A3A2248C05 Q34987366-C795095C-C3B3-4962-9494-61786EC3BAED Q35857181-C30A3E5F-BB55-4E78-8EFF-3FECD3379C9D Q36154430-72E37536-C4A2-4675-8DD7-13D30B755C31 Q36272410-E6F5F484-88C5-4D5E-85F5-66E9BE02061C Q37203104-2B72137C-7898-44D3-8201-2ED9ED54EB56 Q37305115-8001A0EC-7751-48E3-B550-EFF979DFD7FF Q38135045-91721032-5DE9-42C1-8484-2CEF8DBA22D6 Q38206152-B22A7BCE-4CA6-4F57-973E-7FF4E374FF35 Q38592278-A9438544-6948-4441-A468-B36BD40C5E69 Q38721897-ED0F055B-0FD1-4D85-8E6D-AA4B55E86B8E Q38824298-39262C22-FC24-41A3-9959-D2BBE08684A8 Q38866037-ABB4B9E6-9FD4-4160-8959-B6760D855476 Q39138240-27FCB591-7E3A-45C2-B6A0-3C42D12C6FFE Q39395367-AA5E30B9-9747-4549-802E-1716B882D453 Q42507582-203D2485-B9A9-4D4F-9C4F-6D8F0D774FD2 Q47570643-5E123CFB-9070-400F-8986-188679B37CBB Q47975605-42E8B9DD-7A81-4BEB-93D5-2234C4113BF0 Q48153488-B814260D-26E7-4CD7-8774-BE4479D0378C Q49384982-A73E8982-281D-4115-AFB7-3C2851213B14 Q52939870-9798B6E3-B6CC-4BBC-A271-4E0455FB5722 Q54963891-3D921F82-841F-4C03-9B9D-D6023F17EF62 Q55361229-279CC55C-880F-44D9-AF79-A6D4968B706D Q55417861-F499412E-7B1D-41D8-9F35-491AC67E7816 Q58602910-9859D22B-D69F-481E-A952-A501F63EC8E7

P2860

Recommendations for screening and detection of connective tissue disease-associated pulmonary arterial hypertension

http://www.wikidata.org/entity/Q30562538

description

2013 nî lūn-bûn

@nan

2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Recommendations for screening ...... ulmonary arterial hypertension

@ast

Recommendations for screening ...... ulmonary arterial hypertension

@en

type

label

Recommendations for screening ...... ulmonary arterial hypertension

@ast

Recommendations for screening ...... ulmonary arterial hypertension

@en

prefLabel

Recommendations for screening ...... ulmonary arterial hypertension

@ast

Recommendations for screening ...... ulmonary arterial hypertension

@en

P1433

Q30562538-BF49BEEA-0BFE-4EAE-BBC0-D1BEB2EBEB4C

P1476

Q30562538-D3F41204-AC2C-477B-8E93-B89B07312D79

P2093

Q30562538-2AB2F21B-E0BB-45F2-A5BB-B5141CBE095E

Q30562538-354379E6-3CE6-4E11-A14A-CAA0F3F9486F

Q30562538-492DF1DB-6CE4-4730-8BC8-0D32EB15EF12

Q30562538-4F353A07-E4D6-4FF9-BB2E-A07F55255D84

Q30562538-53A9A642-38D4-401C-981B-36DEBD524DB1

Q30562538-6071C87B-2833-49E9-BF73-FD092AE3ADDF

Q30562538-64CE82F3-E962-420F-8170-D20D2E7692EC

Q30562538-67ECA97A-E8B2-40BE-BFF6-F1BD84018E38

Q30562538-82804CE0-316A-4181-955E-01516087E678

Q30562538-A34615AE-586F-437D-A4E9-CB4972F0AD01

P2860

Q30562538-0A8DF45A-214B-45B5-91AC-DE6FBB43D36D

Q30562538-0BD91008-AAAC-4604-B7F7-1EC785650048

Q30562538-0E6428B7-8122-46B6-8103-466E9EBCDC36

Q30562538-10D46EE7-D49B-4BEA-AFE5-2B6821B13A8B

Q30562538-123998D7-ACE5-4854-88B1-44226D92B624

Q30562538-1323E809-F7F5-42E9-A1EE-B83E62AF15D0

Q30562538-166D4C70-C0BE-4BE7-B008-EC92BF4322B4

Q30562538-167A1B3F-073A-4F10-B62E-E4580E964BAD

Q30562538-2083795F-98FA-43D1-9B92-BECFFE02557C

Q30562538-411BD3F6-034A-4FF5-8309-EB0B563E17DD

P304

Q30562538-2AE5E94A-1226-4FA4-A121-8B1B1ED033FE

P31

Q30562538-4B353879-274A-406B-81B4-95F3108F6D57

P356

Q30562538-E7714402-E24C-487B-BBE4-DE2351AEE1FC

P433

Q30562538-2916D264-BFE6-4467-954A-21C5AAB0191F

P478

Q30562538-3522CB18-51E7-468D-9216-2D0E49C60574

P50

Q30562538-BA45F364-514C-4ADF-A914-3E8B1D0D3F52

Q30562538-D492C5C1-5BB3-4C9B-BA1D-61AB4BB2F17B

Q30562538-DB6CFB43-062F-4C73-9B4E-AA06BF74625B

Q30562538-FC23EBE5-CDDA-484D-9231-3D0127F5FCB8

P577

Q30562538-CE38C32B-45A9-4D81-8E70-CD714E4955D8

P5875

Q30562538-0E748F29-D6E1-4780-ADD5-B942D4DE1F0B

P698

Q30562538-B01C393F-1285-4A0B-AB42-C3CC0A53B6B2

P921

Q30562538-7CFDE4B0-D97B-437A-B454-2BF489BEBC57

Q30562538-CCA71AD4-BEE5-4904-8319-3D44676AFFE0

P932

Q30562538-417780F6-62B7-4730-885A-F89C94363F93

P356

P1433

Arthritis & Rheumatology

P1476

Recommendations for screening ...... ulmonary arterial hypertension

@en

P2093

Daniel E Furst

http://www.w3.org/2001/XMLSchema#string

David Langleben

http://www.w3.org/2001/XMLSchema#string

Dinesh Khanna

http://www.w3.org/2001/XMLSchema#string

Heather Gladue

http://www.w3.org/2001/XMLSchema#string

Lorinda Chung

http://www.w3.org/2001/XMLSchema#string

Nezam Altorok

http://www.w3.org/2001/XMLSchema#string

Oliver Distler

http://www.w3.org/2001/XMLSchema#string

Rajeev Saggar

http://www.w3.org/2001/XMLSchema#string

Richard Channick

http://www.w3.org/2001/XMLSchema#string

Scleroderma Foundation and Pulmonary Hypertension Association

http://www.w3.org/2001/XMLSchema#string

P2860

Grading quality of evidence and strength of recommendations

2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia

The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews

2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis

Pulmonary arterial hypertension in connective tissue diseases

QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies

Mixed connective tissue disease--an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA)

N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study

Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study.

Long-term outcome in mixed connective tissue disease: longitudinal clinical and serologic findings.

P304

3194-3201

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ART.38172

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

65

http://www.w3.org/2001/XMLSchema#string

P50

John Fitzgerald

Whitney Townsend

P577

2013-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

256490442

http://www.w3.org/2001/XMLSchema#string

P698

24022584

http://www.w3.org/2001/XMLSchema#string

P921

connective tissue

arterial hypertension

P932

3883571

http://www.w3.org/2001/XMLSchema#string